Dtsch Med Wochenschr 2002; 127(8): 384-389
DOI: 10.1055/s-2002-20221
Übersichten
© Georg Thieme Verlag Stuttgart · New York

Morbus Sudeck - Pathophysiologie und Therapie eines komplexen Schmerzsyndroms

Sudeck`s atrophy: pathophysiology and treatment of a complex pain syndrome M. Weber1 , B. Neundörfer1 , F. Birklein2
  • 1Neurologische Klinik (Direktor: Prof. Dr. B. Neundörfer), Friedrich-Alexander-Universität Erlangen
  • 2Neurologische Universitätsklinik Mainz
Further Information

Publication History

Manuskript-Eingang: 25. Juli 2001

Annahme nach Revision: 14. Januar 2002

Publication Date:
21 February 2002 (online)

Zusammenfassung: Der "Morbus Sudeck", heute Komplexes Regionales Schmerzsyndrom (CRPS) genannt, ist gekennzeichnet durch eine Symptomentrias motorischer, sensibler und autonomer Störungen. Seine klinische Symptomatik ist charakterisiert durch Spontanschmerz und Hyperalgesie, die nicht auf ein Nervenversorgungsgebiet beschränkt bleiben und dem auslösenden Ereignis nicht angemessen sind. Die Pathophysiologie dieser Erkrankung ist noch immer nicht endgültig geklärt, der Großteil therapeutischer Möglichkeiten ist noch immer rein symptomatisch. Der momentane Stand der Forschung zum CRPS ermöglicht jedoch bereits mehr Einblicke in die Grundlagen der Krankheit als noch vor wenigen Jahren und ermöglicht auch Anfänge einer pathophysiologisch orientierten Therapie.

Sudeck`s atrophy: pathophysiology and treatment of a complex pain syndrome

Summary: The "Morbus Sudeck" or Complex Regional Pain Syndrome (CRPS) forms a typical triad of motor, sensory and autonomic symptoms. It is clinically characterized by spontaneous pain and hyperalgesia not limited to a single nerve territory and disproportionate to the inciting event. An underlying pathophysiology which could explain the whole symptomatology of CRPS is still unknown. Therefore, nowadays therapy is still symptomatic. However, recent research led to a better understanding of the disease and to the beginning of a pathophysiologically orientated therapy.

Literatur

  • 1 Ali Z, Raja S N, Wesselmann U, Fuchs P N, Meyer R A, Campbell J N. Intradermal injection of norepinephrine evokes pain in patients with sympathetically maintained pain.  Pain. 2000;  88 161-168
  • 2 Arnold J MO, Teasell R W, MacLeod A P, Brown J E, Carruthers S G. Increased venous alpha-adrenoreceptor responsiveness in patients with reflex sympathetic dystrophy.  Ann Int Med. 1993;  118 619-621
  • 3 Birklein F, Riedl B, Claus D, Neundörfer B. Pattern of autonomic dysfunction in time course of complex regional pain syndrome.  Clin Aut Res. 1998;  8 79-85
  • 4 Birklein F, Riedl B, Claus D, Neundörfer B, Handwerker H O. Cutaneous norepinephrine application in complex regional pain syndrome.  Eur J Pain. 1997;  1 123-132
  • 5 Birklein F, Riedl B, Neundörfer B, Handwerker H O. Sympathetic vasoconstrictor reflex pattern in patients with complex regional pain syndrome.  Pain. 1998;  75 93-100
  • 6 Birklein F, Riedl B, Sieweke N, Weber M, Neundorfer B. Neurological findings in complex regional pain syndromes - analysis of 145 cases.  Acta Neurol Scand. 2000;  101 262-269
  • 7 Blumberg H. Clinical and pathophysiological aspects of reflex sympathetic dystrophy and sympathetically maintained pain. Weinheim, New York: VCH In: Jänig W., Schmidt R.F., editors. Reflex Sympathetic Dystrophy 1991: 29-49
  • 8 Bonica J J. Causalgia and Other Reflex Sympathetic Dystrophies. New York: Raven Press In: JJ Bonica, editors. Advances in Pain Research and Therapy 1979: 141-166
  • 9 Campell J N, Raja S N, Selig D K, Belzberg A J, Meyer R A. Diagnosis and management of sympathetically maintained pain. Seattle: IASP Press In: HI Fields, JC Liebeskind, editors. Progress in Pain research and Management 1994: 85-99
  • 10 Christensen K, Jensen E M, Noer I. The reflex sympathetic dystrophy syndrome; response to treatment with systemic corticosteroids.  Acta Chir Scand. 1982;  148 653-655
  • 11 Deuschl G, Blumberg H, Lücking C H. Tremor in Reflex Sympathetic Dystrophy.  Arch Neurol. 1991;  48 1247-1253
  • 12 Drummond P D, Finch P M, Smythe G A. Reflex sympathetic dystrophy: The significance of differing plasma catecholamine concentrations in affected and unaffected limbs.  Brain. 1991;  114 2025-2036
  • 13 Gobelet C, Waldburger M, Meier J L. The effect of adding calcitonin to physical treatment on reflex sympathetic dystrophy.  Pain. 1992;  48 171-175
  • 14 Hannington-Kiff J G. Antisympathetic drugs in limbs. Edinburgh: Churchill Livingstone In: Wall P, Melzack R, editors. Textbook of Pain 1984: 566-573
  • 15 Holzer P. Neurogenic vasodilatation and plasma leakage in the skin.  Gen Pharmacol. 1998;  30 5-11
  • 16 Kemler M A, van de Vusse A C, Berg-Loonen E M, Barendse G A, van Kleef M, Weber W E. HLA-DQ1 associated with reflex sympathetic dystrophy.  Neurology. 1999;  53 1350-1351
  • 17 Kingery W S. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes.  Pain. 1997;  73 123-139
  • 18 Kingery W S, Agashe G S, Sawamura S, Davies M F, Clark J D, Maze M. Glucocorticoid inhibition of neuropathic hyperalgesia and spinal Fos expression.  Anesth Analg. 2001;  92 476-482
  • 19 Kurvers H A, Jacobs M J, Beuk R J, van den Wildenberg F A, Kitslaar P J, Slaaf D W, Reneman R S. Reflex sympathetic dystrophy: evolution of microcirculatory disturbances in time.  Pain. 1995;  60 333-340
  • 20 Levine J D, Taiwo Y O, Collins S D, Tam J K. Noradrenaline hyperalgesia is mediated through interaction with sympathetic postganglionic neurone terminals rather than activation of primary afferent nociceptors.  Nature. 1986;  323 158-160
  • 21 Lynch M E. Psychological aspects of reflex sympathetic dystrophy: a review of the adult and paediatric literature.  Pain. 1992;  49 337-347
  • 22 Menkes D B, Gallager D W, Reinhard J F, Aghajanian G K. Alpha-1 adrenoceptor denervation supersensitivity in brain: physiological and receptor binding studies.  Brain Res. 1983;  272 1-12
  • 23 Ochoa J L. Reflex Sympathetic Dystrophy: A Disease of medical Understanding.  Clin J Pain. 1992;  8 363-366
  • 24 Oerlemans H M, Oostendorp R A, de Boo T, Goris R J. Pain and reduced mobility in complex regional pain syndrome I: outcome of a prospective randomised controlled clinical trial of adjuvant physical therapy versus occupational therapy.  Pain. 1999;  83 77-83
  • 25 Price D D, Long S, Wilsey B, Rafii A. Analysis of peak magnitude and duration of analgesia produced by local anesthetics injected into sympathetic ganglia of complex regional pain syndrome patients.  Clin J Pain. 1998;  14 216-226
  • 26 Ravin N. New hair growth over fracture sites.  N Engl J Med. 1990;  323 350
  • 27 Reeh P W, Steen K H. Tissue acidosis in nociception and pain.  Prog Brain Res. 1996;  113 143-151
  • 28 Riedl B, Beckmann T, Neundorfer B, Handwerker H O, Birklein F. Autonomic failure after stroke - is it indicative for pathophysiology of complex regional pain syndrome?.  Acta Neurol Scand. 2001;  103 27-34
  • 29 Sato J, Perl E R. Adrenergic excitation of cutaneous pain receptors induced by peripheral injury.  Science. 1991;  251 1608-1610
  • 30 Schmelz M, Michael K, Weidner C, Schmidt R, Torebjork H E, Handwerker H O. Which nerve fibers mediate the axon reflex flare in human skin?.  Neuroreport. 2000;  11 645-648
  • 31 Sieweke N, Birklein F, Riedl B, Neundorfer B, Handwerker H O. Patterns of hyperalgesia in complex regional pain syndrome.  Pain. 1999;  80 171-177
  • 32 Sudeck P. Die so genannte Knochenatrophie als Entzündungsvorgang.  Chirurg. 1942;  15 449-457
  • 33 Tremont-Lukats I W, Megeff C, Backonja M M. Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy.  Drugs. 2000;  60 1029-1052
  • 34 van-der-Laan L, ter-Laak H J, Gabreels F A, Gabreels F, Goris R J. Complex regional pain syndrome type I (RSD): pathology of skeletal muscle and peripheral nerve.  Neurology. 1998;  51 20-25
  • 35 van de Beek W J, van Hilten J J, Roep B O. HLA-DQ1 associated with reflex sympathetic dystrophy.  Neurology. 2000;  55 457-458
  • 36 Varenna M, Zucchi F, Ghiringhelli D, Binelli L, Bevilacqua M, Bettica P, Sinigaglia L. Intravenous clodronate in the treatment of reflex sympathetic dystrophy syndrome: A randomized, double blind, placebo controlled study.  J Rheumatol. 2000;  27 1477-1483
  • 37 Veldman P HJM, Reynen H M, Arntz I E, Goris R JA. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients.  Lancet. 1993;  342 1012-1016
  • 38 Wasner G, Schattschneider J, Heckmann K, Maier C, Baron R. Vascular abnormalities in reflex sympathetic dystrophy (CRPS I): mechanisms and diagnostic value.  Brain. 2001;  124 587-599
  • 39 Watson C P, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia.  Neurology. 1998;  50 1837-1841
  • 40 Weber M, Birklein F, Neundorfer B, Schmelz M. Facilitated neurogenic inflammation in complex regional pain syndrome.  Pain. 2001;  91 251-257
  • 41 Woolf C J, Mannion R J. Neuropathic pain: aetiology, symptoms, mechanisms, and management.  Lancet. 1999;  353 1959-1964
  • 42 Wurnig C, Kotz R. Algodystrophy in pregnancy.  Z Orthop Ihre Grenzgeb. 1991;  129 146-150
  • 43 Zufferey P, Boubaker A, Bischof D A, So A K, Duvoisin B. Prognostic aspects of scintigraphy and MRI during the first 6 months of reflex sympathetic dystrophy of the distal lower limb: a preliminary prospective study of 4 cases.  J Radiol. 1999;  80 373-377
  • 44 Zuurmond W W, Langendijk P N, Bezemer P D, Brink H E, de Lange J J, van loenen A C. Treatment of acute reflex sympathetic dystrophy with DMSO 50 % in a fatty cream.  Acta Anaesthesiol Scand. 1996;  40 364-367

Korrespondenz

Dr. Margarete Weber

Neurologische Klinik

Schwabachanlage 6

91054 Erlangen

Phone: 09131/8533001

Fax: 09131/8534436

Email: margarete.weber@neuro.med.uni-erlangen.de

    >